Basic characteristics of included studies.

<p>Basic characteristics of included studies.</p

Flow diagram of selected studies.

<p>Flow diagram of selected studies.</p

Forest plot showing efficacy of 5-NIs in the treatment of giardiasis; stratified by type of drug.

<p>Forest plot showing efficacy of 5-NIs in the treatment of giardiasis; stratified by type of drug.</p

Funnel plot assessing publication bias.

<p>Funnel plot assessing publication bias.</p

Forest plot showing efficacy of 5-NIs in the treatment of giardiasis.

<p>Forest plot showing efficacy of 5-NIs in the treatment of giardiasis.</p

Cochrane assessment of bias risk of randomized controlled trials.

<p>Cochrane assessment of bias risk of randomized controlled trials.</p

Modified Rankin Score 0–2 at 90 days expressed as absolute risk differences (ARD).

<p>Modified Rankin Score 0–2 at 90 days expressed as absolute risk differences (ARD).</p

Forest plots showing modified Rankin Score 0–2 at 90 days between endovascular therapy and controls.

<p><b>A:</b> All studies. <b>B:</b> Subgroup 1: IA thrombolysis only versus mechanical device use. <b>C:</b> Subgroup 2: Comparator includes IV thrombolysis versus no thrombolysis. <b>D:</b> Subgroup 3: Studies that required vessel occlusion versus studies did not require vessel occlusion status.</p

Flow diagram of selected studies.

<p>Flow diagram of selected studies.</p